
Afghan Widow
LegendaryTHC
9.02%
CBD
0.5%
Genetics Split
A balanced Hybrid strain that combines the relaxing qualities of Indica with mild uplifting effects.
Explore More
Terpene Fingerprint
Relative terpene levels from lab and source data
THC in this profile
9.02% THC
Growing Information
Flowering Time
8–9 weeks
Difficulty
moderate
Height (Indoor)
100-150cm
Yield (Indoor)
450-550 g/m²
About Afghan Widow
Afghan Widow is a strain with deep relaxing qualities that immediately envelop the body in a calming aura. This mid-level sedation is pleasant but not debilitating. However, with continued consumption, this strain may yield benefits for patients treating insomnia, nausea, physical discomfort, and some cancer treatment side effects. Afghan Widows lineage is a common sense cross of Afghan Kush and White Widow.
Where to Buy Seeds
We may earn a commission from purchases made through these links.
Frequently Asked Questions about Afghan Widow
Is Afghan Widow an Indica, Sativa, or Hybrid?
Afghan Widow is classified as a indica cannabis strain bred from a genetic cross of Afghan Kush × null.
What cannabinoid content is reported for Afghan Widow?
Afghan Widow: 9.0% THC and 0.5% CBD reported in our data. The THC figure, when present, is the upper end of the reported range, not a typical measured dose. Potency can vary across harvests, phenotypes, and growing conditions.
What are the common effects of Afghan Widow?
Our data sources report these effects for Afghan Widow: relaxed, happy, uplifted. Individual experiences vary.
What does Afghan Widow taste and smell like?
Our data sources list flavors of citrus, earthy, spicy and terpenes such as Caryophyllene, Limonene, Myrcene for Afghan Widow.
If You Like Afghan Widow, Try...
Shared reported terpene or flavor notes; effects may differ
Similar Strains
Strawberry Kush
INDICATHC 16.55%
Witches Weed
INDICATHC 19%
Sour Best Afghani - 11
INDICATHC 16.1%
Moonwalker OG
INDICATHC 17.7%
Strawberry Pop Rocks
INDICARaspberry Dosido
INDICATHC 23.6%
Pink Sunset
INDICATHC 17.9%
Brand x
INDICATHC 24%


